New research published in Lab on a Chip demonstrates 100x sensitivity improvement on Simoa; marks significant advancement in sensitivity for industry leading detection platform Quanterix has pioneered ...

Findings by leading researchers demonstrate the promise and relevance of Simoa in vast application areas BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing ...

LEXINGTON, Mass., Oct. 11, 2012 /PRNewswire/ -- Quanterix Corporation announced today that the Journal of Virological Methods published a key study describing the application of its ultra-sensitive ...

The Simoa Disc is the first diagnostic developed using Sony DADC's optical disc manufacturing technology; will be used in Simoa technology to improve testing quality in life science research LEXINGTON ...

Quanterix Corporation (NASDAQ: QTRX), announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea ...

LEXINGTON, Mass. Quanterix Corporation, a leader in high definition diagnostics, today announced that The Journal of Clinical Chemistry has published a new study in which its single molecule array ...

Shares of molecular diagnostic company – Myriad Genetics, Inc. MYGN inched up 1% to close at $35.13 on Friday, subsequent to the launch of its latest immunoassay service by the company’s wholly owned ...

The devastation of a brain injury can be obvious. Sometimes. Yet other times, the extent of a traumatic injury is much more difficult to evaluate and quantify. This is particularly the case for mild ...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has successfully ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...